CRO Insurance for Clinical Research Businesses
Specialist insurance advice for Contract Research Organisations delivering clinical trial management, monitoring, data, regulatory and related research services.
Request a review
Tell us what your CRO does, where trials are conducted and what your sponsor contracts require.
A CRO’s largest exposure is often not the same as the sponsor’s. A sponsor may delegate trial-related duties to a Contract Research Organisation, but the CRO can still face its own professional liability for mistakes in the services it agrees to perform. That can include monitoring failures, data integrity problems, randomisation errors, recruitment failures, regulatory mistakes, vendor oversight issues and contractual disputes that delay or invalidate a study.
Why CRO insurance is different
Professional services, contracts and clinical risk overlap
CROs sit between sponsors, investigators, trial sites, vendors, laboratories, technology providers and regulators. A mistake can cause bodily injury, pure financial loss, a missed milestone, unusable data, a delayed submission or the need to repeat part of a trial.
Professional liability
Errors or omissions in trial management, monitoring, regulatory services, data handling, biostatistics or other contracted professional services.
Contractual exposure
Claims can arise from an alleged failure to meet the CRO’s agreed scope, timelines, specifications, quality standards or deliverables.
Clinical trial exposure
Participant injury and trial-specific liability may need separate treatment depending on whether the CRO has assumed sponsor, site, medical or other clinical responsibilities.
Who we assist
CRO and clinical research service businesses
We can review insurance for full-service and specialist CROs across a wide range of outsourced clinical research activities.
- Full-service Contract Research Organisations.
- Clinical operations and project management providers.
- Site management and investigator network service providers.
- Clinical monitoring and trial oversight businesses.
- Data management, randomisation, eCOA, ePRO, EDC and clinical technology providers.
- Biostatistics and statistical programming businesses.
- Regulatory affairs and submission support providers.
- Pharmacovigilance and safety reporting providers, where undertaken.
- Medical writing and clinical documentation businesses.
- Patient recruitment and retention service providers.
- Specialist medical-device clinical investigation CROs.
The insurance programme
Cover a CRO may need
| Cover | Why it matters to a CRO |
|---|---|
| Professional Indemnity / E&O | For certain claims alleging a negligent act, error or omission in professional services. For CROs, the wording should be reviewed carefully for contractual liability, financial loss and the actual services being provided. |
| Public & Products Liability | For certain third-party bodily injury or property damage arising from the CRO’s premises, operations or products where applicable. |
| Clinical Trials Liability | May be required where the CRO assumes clinical trial liability, acts as sponsor, is contractually required to insure participant injury, or otherwise carries a trial-specific exposure. It should not be assumed that every CRO automatically needs sponsor clinical-trial cover. |
| Cyber & Privacy | CROs can hold sensitive health information, trial data, credentials and commercially sensitive sponsor information. Cyber events can also interrupt study systems or compromise data integrity. |
| Management Liability | For certain claims involving directors, officers, employment practices, statutory liability and other management exposures, depending on the policy. |
| Property & Business Interruption | For offices, equipment, laboratory assets where applicable, and interruption following insured physical damage. |
| Crime / Social Engineering | Relevant where the business handles sponsor funds, vendor payments or faces employee theft and fraud risks. |
| Travel & Workers Compensation | For staff travelling to sites and the statutory workers compensation requirements that apply to employees. |
There is no single standard CRO policy. The right structure depends on what the CRO actually does, which responsibilities are delegated, where trials are conducted, what the contracts require and whether the CRO assumes any sponsor or participant-injury obligations.
Critical distinction
CRO responsibility is not the same as sponsor responsibility
In Australia, a trial sponsor can delegate trial-related duties and functions to a CRO or other service provider. However, the Australian trial sponsor retains overall responsibility for the conduct of the trial and for delegated functions. The allocation of duties should therefore be clearly documented.
From an insurance perspective, this distinction matters. A CRO should be insured for the professional services and contractual obligations it actually assumes. If it also becomes the Australian sponsor, accepts responsibility for participant injury, provides medical services, or takes on other sponsor functions, the insurance programme may need to broaden accordingly.
CRO exposure 01
Data integrity and study validity
A CRO can perform every visible task in a study correctly and still face a major claim if a system, process or professional error undermines the data. Incorrect randomisation, database configuration, data transfer, statistical programming, protocol deviations or failures in quality control can make trial data unreliable or unusable.
The financial loss can be substantial: recruitment may have to be repeated, study timelines extended, sites reopened, vendors re-engaged and sponsor milestones missed. CRO insurance should therefore be tested for pure financial loss and not just bodily injury.
CRO exposure 02
Breach of contract and scope of services
Many CRO claims arise out of the service contract rather than a simple allegation of negligence. Master Services Agreements, Statements of Work and Work Orders can impose deadlines, service levels, warranties, indemnities, regulatory obligations and responsibility for subcontractors.
Some professional indemnity policies respond only to negligence and may not respond to a contractual obligation that goes beyond the duty the CRO would otherwise have at law. We therefore review the insurance wording alongside key contractual obligations where possible.
CRO exposure 03
Monitoring, protocol compliance and delegated duties
Clinical monitoring, safety reporting, site oversight and regulatory support can carry significant exposure. A failure to identify repeated protocol deviations, escalate safety information, maintain required documentation or perform a delegated function within the required timeframe can lead to sponsor disputes, regulatory scrutiny and study delay.
The question for insurance is not simply whether the activity is called “clinical research”. The policy should reflect the specific delegated function the CRO has agreed to perform.
CRO exposure 04
Patient recruitment and informed-consent processes
CROs may support recruitment, site activation, investigator communications and trial documentation. Depending on the CRO’s role, allegations can arise if recruitment material is inaccurate, eligibility criteria are applied incorrectly, required documentation is not maintained or a process failure contributes to participant injury.
Where investigators and sites retain responsibility for informed consent and medical care, that responsibility should not be casually transferred to the CRO by broad contractual drafting without checking the insurance consequences.
CRO exposure 05
Medical-device clinical investigations
CROs running medical-device studies can face a different risk profile from a conventional low-risk research project. The intended use of the device, invasiveness, duration of use, body location and overall device risk can affect the seriousness of a trial-management error.
A CRO managing a study involving a high-risk or implantable device is not automatically the manufacturer or sponsor. However, the consequences of an error in monitoring, reporting, protocol management or delegated safety functions may be more severe. We consider these activities when presenting the risk to insurers.
CRO exposure 06
Technology, cyber and privacy risk
Modern CROs increasingly rely on electronic trial systems, cloud platforms, randomisation tools, ePRO/eCOA applications, EDC environments and integrations with sponsor and site systems. A software or configuration error can become a professional indemnity claim, while a security incident can become a cyber or privacy claim.
These policies should be reviewed together so an event involving data corruption, privacy breach and sponsor financial loss does not fall awkwardly between separate policy sections.
CRO exposure 07
Multinational trials and overseas contracts
CROs frequently perform services across multiple jurisdictions. Territorial and jurisdiction clauses, US and Canadian exposure, local admitted insurance requirements, certificates of insurance, additional insured requests, contractual indemnities and governing-law provisions can materially change the risk.
A global sponsor contract should not be assumed to fit an Australian-only PI policy. The insurance structure should be checked before the CRO accepts new countries or materially changes its scope.
How claims can arise
Illustrative CRO claim scenarios
These examples are illustrative only and are not promises that a particular policy will respond.
Randomisation system error
A CRO’s trial system fails to randomise participants correctly. A large part of the study becomes unusable and the sponsor alleges breach of contract and seeks the cost of repeating work and delaying the programme.
Recruitment system failure
A recruitment or response-system error compromises trial data after a large number of participants have already been enrolled. The sponsor alleges the CRO failed to provide services to the agreed specification.
Monitoring failure
A monitor does not identify repeated protocol deviations at a site. The issue is discovered later during an audit, creating remediation costs, delay and a dispute about whether the CRO met its contractual obligations.
Safety-reporting delay
A delegated safety-reporting task is not escalated within the required timeframe. The sponsor incurs additional regulatory and project costs and alleges the CRO failed to perform the delegated service correctly.
Privacy incident
Participant information is exposed through a compromised trial system. The CRO faces incident response costs and potential third-party allegations while the sponsor seeks recovery under the service contract.
Preparing a CRO submission
What insurers will want to understand
A strong submission should describe the CRO’s real service model rather than relying on a broad label such as “clinical research services”.
- Exact services provided and which are subcontracted.
- Phase I-IV, observational, device or other studies supported.
- Countries in which services are performed and whether US exposure exists.
- Annual revenue split by service type and geography.
- Largest sponsor contracts and maximum contract values.
- Use of EDC, randomisation, ePRO/eCOA, safety and other clinical technology.
- Whether the CRO acts as sponsor, Australian sponsor, local representative or site operator.
- Whether any medical professionals are employed or contracted and what clinical care they provide.
- Quality management, SOPs, audit processes, incident history and claims.
- Key indemnities, insurance clauses and limitation-of-liability provisions in sponsor contracts.
Common questions
Frequently asked CRO insurance questions
Is ordinary Professional Indemnity enough for a CRO?
Not always. A generic PI wording may not contemplate clinical research, bodily injury arising from services, contractual liability, trial-specific exposures or the technology and data risks of a CRO. The actual wording and declared activities need review.
Does the sponsor’s clinical-trial policy automatically protect the CRO?
No. A sponsor policy may include or indemnify certain contractors in defined circumstances, but a CRO should not assume it replaces the CRO’s own PI, cyber or other insurance. The sponsor policy, CRO contract and the CRO’s own programme should be checked together.
Can breach-of-contract claims be covered?
Potentially, depending on the policy wording and the nature of the obligation. Some PI policies are narrower and focus on negligence only. Contractual liability that exceeds the CRO’s ordinary legal duty can also create gaps.
What if the CRO also acts as Australian sponsor?
That can materially change the exposure. Sponsor responsibilities, trial authorisations, participant injury arrangements and clinical-trial liability should be reviewed separately rather than simply extending the CRO’s normal PI description.
Do device trials require different consideration?
Yes. The device’s intended use, invasiveness, duration of use and risk classification can affect the seriousness of the study exposure. The CRO’s own role still needs to be separated from the manufacturer’s and sponsor’s responsibilities.
Specialist CRO insurance advice
Review the insurance behind your CRO contracts
Mercantile Insurance Brokers can review the services you perform, the responsibilities you assume and the insurance requirements imposed by sponsors. We can then structure a programme around your actual CRO exposure rather than treating the business as a generic consultant.
Related: Medical Research Insurance · Medical Device Insurance · Pharmaceutical Insurance